MUNICH, March 14, 2019 /PRNewswire/ -- Dornier MedTech
(Dornier), the global leader in stone management that pioneered
Extracorporeal Shockwave Lithotripter (ESWL) technology, today
announced that it will launch its new Dornier OptiVision
state-of-the-art Next-Generation Digital Image Processing
technology for digital radiography at the 34th Annual
EAU Congress in Barcelona, held
from 15 to 19 March 2019.
Logo - https://mma.prnewswire.com/media/836149/DMT_Logo.jpg
Dornier OptiVision will offer world class digital image
processing which allows users to identify and eliminate stones
without cumbersome manual post-processing; Dornier OptiVision has
been designed to deliver sharp image details and comfortable
reading, especially in the field of stone treatment and
Endourology.
The software utilizes multi-frequency processing to
significantly enhance image quality compared to standard Urology
images. Dornier OptiVision will enable its users to strike an
optimal balance between low radiation dose and high image quality,
serving as a powerful tool in the management, and potential
reduction of patient radiation dosage in imaging procedures.
Dornier OptiVision also represents a significant step for the
company's ambitions in two areas:
- Developing the Highly Acclaimed Dornier Delta® III
into a platform for both Stone Treatment and Day-to-Day Endourology
procedures
- Extending the suite of SmartLitho™ functionality that
allows global ESWL users access to the power of software, big data,
and analytics in the field of Urology.
The company's other developments in
SmarthLitho™ functionality will also be showcased at the EAU
Congress, featuring in 2 of the 4 poster presentations being made
this year from the group.
Georg Frosch, Assistant General
Manager Europe North, Middle East
& Africa said: "The launch
of our Dornier OptiVision technology signifies our commitment to
make ESWL relevant for tomorrow's urologists. OptiVision is another
example of our commitment to innovate and create a portfolio of
solutions that increase productivity, make diagnosis simpler and
create smoother workflows for urologists."
Previews of the Dornier OptiVision technology will take place at
the Dornier MedTech booth (Hall 8, Booth K26).
Ends
About Dornier MedTech
Dornier MedTech is headquartered in Munich, Germany, and is a full subsidiary of
Accuron MedTech.
Dornier is a medical device company focused on providing leading
technology and improving life by delivering scientifically superior
products and solutions to physicians, healthcare providers and
research groups involved in urological care.
As pioneers of the lithotripsy and a variety of surgical lasers,
Dornier's 40 years of innovation and service have made it one of
the most trusted MedTech companies in the industry.
About Accuron MedTech Group
Accuron MedTech Group is one of the largest medical device
companies in Southeast Asia. It is
a vertically integrated medical device company and a global medical
technology leader with a core focus in urology devices and
services.
Headquartered in Singapore,
with operations in US, Germany,
Spain, France, Italy, China,
Malaysia and Japan, the Company serves millions of patients
and physicians in about 100 countries worldwide. Accuron MedTech
makes strategic investments in disruptive medical technology
companies, strengthening its portfolio of healthcare solutions for
customers around the world.
Accuron MedTech is an independent division of Accuron
Technologies, a wholly-owned subsidiary of Temasek Holdings. For
more information on Accuron MedTech, please visit
www.accuronmedtech.com.